- Investing Ideas
- /
- Danish Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Danish Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
2
0 new
High return on equity, past performance and sound balance sheet.
2 companies
ChemoMetec
Market Cap: DKK 9.3b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 532.00
7D
-4.1%
1Y
22.9%
Genmab
Market Cap: DKK 89.9b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB
DKK 1,414.00
7D
-14.8%
1Y
-30.9%
Page 1 of 1